CYTK Q1 2017 Earnings — Cytokinetics, Incorporated Revenue & Financial Results | Market Cap Arena

CYTKCytokinetics, Incorporated

$8B

Q1 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M-50.7% YoY

Gross Profit

-$15M-364.5% margin

Operating Income

-$23M-559.9% margin

Net Income

-$26M-622.9% margin

EPS (Diluted)

$-0.62

QoQ Revenue Growth

-87.5%

Cash Flow

Operating Cash Flow

-$21M

Free Cash Flow

-$22M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$265M

Total Liabilities

$170M

Stockholders' Equity

$95M

Cash & Equivalents

$49M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$8M	-50.7%
Gross Profit	-$15M	-$5M	-196.0%
Operating Income	-$23M	-$12M	-94.5%
Net Income	-$26M	-$12M	-107.7%